Lifespan Cardiovascular Institute
URL COPIED!
Ischemia Physician
Primary objective is to determine whether an invasive (INV) strategy of routine early cardiac catheterization with intent for optimal revascularization in addition to optimal medical therapy in patients with stable ischemic heart disease (SIHD) and at least moderate ischemia on stress imaging reduces the incidence of the composite of cardiovascular death or nonfatal myocardial infarction compared with a conservative (CON) strategy of optimal medical therapy alone with cardiac catheterization and revascularization reserved for patients with refractory angina, acute coronary syndrome, acute ischemic heart failure or resuscitated cardiac arrest
Patients will be followed for 18-24 months.
For more information, please contact the study coordinator:
Cardiovascular Research
The Miriam Hospital
Lori-Ann DeSimone
Tel: 401-793-4105
Patients will be followed for 18-24 months.
For more information, please contact the study coordinator:
Cardiovascular Research
The Miriam Hospital
Lori-Ann DeSimone
Tel: 401-793-4105
Lifespan Cardiovascular Institute
- Our Services
- Meet the Team
- Patient Stories
-
Cardiovascular Research
-
Cardiovascular Institute Current Studies
- Absorb III Patient
- Absorb III Physician
- SILVER-AMI Study Patient
- SILVER-AMI Study Physician
- Secret Trial Patient
- Secret Trial Physician
- Lutonix Patient
- Lutonix Physician
- ORBIT-AF II Patient
- ORBIT-AF II Physician
- RenalGuard Trial Patient
- RenalGuard Trial Physician
- Ischemia Study Patient
- Ischemia Physician
- Mind Your Heart Study II
- Clinical and Translational Research Center
- Research Interests
-
Cardiovascular Institute Current Studies
- Lifespan Cardiovascular Institute Awards and Certifications
- Schedule an Appointment at the Lifespan Cardiovascular Institute
- Heart Health and Exercise
- What Are the Symptoms of a Heart Attack?
- Best Heart Health Foods
- Giving to the Lifespan Cardiovascular Institute
- The Lifespan Cardiovascular Institute in the News